A BILL 
To amend title XVIII of the Social Security Act to prohibit 
price concessions with respect to insulin drugs and excep-
tions under part D of Medicare, and for other purposes. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘The Insulin Cost Re-
4
duction Act’’. 
5
02:13 Oct 21, 2021
H5623
2 
•HR 5623 IH
SEC. 2. PROHIBITION OF PRICE CONCESSIONS WITH RE-
1
SPECT TO INSULIN DRUGS AND EXCEPTIONS 
2
UNDER PART D OF MEDICARE. 
3
(a) IN GENERAL.—Section 1860D–2(d)(1) of the So-
4
cial Security Act (42 U.S.C. 1395w–102(d)(1)) is amend-
5
ed— 
6
(1) in subparagraph (A), by striking ‘‘Under’’ 
7
and inserting ‘‘Subject to subparagraph (D), 
8
under’’; and 
9
(2) by adding at the end the following new sub-
10
paragraph: 
11
‘‘(D) PROHIBITION OF PRICE CONCESSIONS 
12
WITH RESPECT TO INSULIN DRUGS AND EXCEP-
13
TIONS.—For plan years beginning 180 days 
14
after the date of the enactment of this subpara-
15
graph, no price concessions negotiated between 
16
manufacturers and a prescription drug plan or 
17
MA–PD plan shall be permitted with respect to 
18
an insulin drug (as determined by the Sec-
19
retary), unless— 
20
‘‘(i) such price concessions provided 
21
under such a plan shall be provided to en-
22
rollees of such a plan at pharmacies or by 
23
mail order service at the point-of-sale of 
24
such insulin drugs; or 
25
02:13 Oct 21, 2021
H5623
3 
•HR 5623 IH
‘‘(ii) the cost-sharing required with re-
1
spect to such insulin drugs shall be cal-
2
culated in a manner that takes into ac-
3
count any amounts received pursuant to 
4
such price concessions.’’. 
5
Æ 
02:13 Oct 21, 2021
H5623
